Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Irritable Bowel Syndrome (IBS) market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Irritable Bowel Syndrome (IBS) market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Irritable Bowel Syndrome (IBS) market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Irritable Bowel Syndrome (IBS) products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Irritable Bowel Syndrome (IBS) products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Irritable Bowel Syndrome (IBS) market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Irritable Bowel Syndrome (IBS) development has been the leading industry trend of Irritable Bowel Syndrome (IBS) market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Irritable Bowel Syndrome (IBS) Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
IBS-D Drug, IBS-C Drug, Other |
| By Application Outlook |
Women, Men, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals, McNeil Consumer Healthcare, Sebela Pharmaceuticals, Astellas Pharmaceuticals, IM HealthScience |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Allergan
- Valeant Pharmaceuticals
- Takeda
- Sucampo Pharmaceuticals
- McNeil Consumer Healthcare
- Sebela Pharmaceuticals
- Astellas Pharmaceuticals
- IM HealthScience
IRRITABLE BOWEL SYNDROME (IBS) Market, By Type
- IBS-D Drug
- IBS-C Drug
- Other
IRRITABLE BOWEL SYNDROME (IBS)Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Irritable Bowel Syndrome (IBS) Market Overview
1.1 Irritable Bowel Syndrome (IBS) Product Overview
1.2 Irritable Bowel Syndrome (IBS) Market Segment by Type
1.2.1 IBS-D Drug
1.2.2 IBS-C Drug
1.2.3 Other
1.3 Global Irritable Bowel Syndrome (IBS) Market Size by Type
1.3.1 Global Irritable Bowel Syndrome (IBS) Sales and Growth by Type
1.3.2 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Type (2013-2018)
1.3.3 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2013-2018)
1.3.4 Global Irritable Bowel Syndrome (IBS) Price by Type (2013-2018)
2 Global Irritable Bowel Syndrome (IBS) Market Competition by Company
2.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Company (2013-2018)
2.2 Global Irritable Bowel Syndrome (IBS) Revenue and Share by Company (2013-2018)
2.3 Global Irritable Bowel Syndrome (IBS) Price by Company (2013-2018)
2.4 Global Top Players Irritable Bowel Syndrome (IBS) Manufacturing Base Distribution, Sales Area, Product Types
2.5 Irritable Bowel Syndrome (IBS) Market Competitive Situation and Trends
2.5.1 Irritable Bowel Syndrome (IBS) Market Concentration Rate
2.5.2 Global Irritable Bowel Syndrome (IBS) Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Irritable Bowel Syndrome (IBS) Company Profiles and Sales Data
3.1 Allergan
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.1.4 Main Business Overview
3.2 Valeant Pharmaceuticals
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.2.4 Main Business Overview
3.3 Takeda
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.3.4 Main Business Overview
3.4 Sucampo Pharmaceuticals
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.4.4 Main Business Overview
3.5 McNeil Consumer Healthcare
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.5.4 Main Business Overview
3.6 Sebela Pharmaceuticals
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.6.4 Main Business Overview
3.7 Astellas Pharmaceuticals
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.7.4 Main Business Overview
3.8 IM HealthScience
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Irritable Bowel Syndrome (IBS) Product Category, Application and Specification
3.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin(2013-2018)
3.8.4 Main Business Overview
4 Irritable Bowel Syndrome (IBS) Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Irritable Bowel Syndrome (IBS) Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Irritable Bowel Syndrome (IBS) Sales and Revenue by Regions
4.2.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Regions (2013-2018)
4.2.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Regions (2013-2018)
4.2.3 Global Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin (2013-2018)
4.3 North America Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Irritable Bowel Syndrome (IBS) Application/End Users
5.1 Irritable Bowel Syndrome (IBS) Segment by Application
5.1.1 Women
5.1.2 Men
5.2 Global Irritable Bowel Syndrome (IBS) Product Segment by Application
5.2.1 Global Irritable Bowel Syndrome (IBS) Sales by Application
5.2.2 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Application (2013-2018)
6 Global Irritable Bowel Syndrome (IBS) Market Forecast
6.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue Forecast (2018-2025)
6.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Growth Rate Forecast (2018-2025)
6.1.1 Global Irritable Bowel Syndrome (IBS) Revenue and Growth Rate Forecast (2018-2025)
6.2 Global Irritable Bowel Syndrome (IBS) Forecast by Regions
6.2.1 North America Irritable Bowel Syndrome (IBS) Sales and Revenue Forecast (2018-2025)
6.2.2 Europe Irritable Bowel Syndrome (IBS) Sales and Revenue Forecast (2018-2025)
6.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Revenue Forecast (2018-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Irritable Bowel Syndrome (IBS) Sales and Revenue Forecast (2018-2025)
6.2.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Revenue Forecast (2018-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Irritable Bowel Syndrome (IBS) Forecast by Type
6.3.1 Global Irritable Bowel Syndrome (IBS) Sales and Revenue Forecast by Type (2018-2025)
6.3.2 IBS-D Drug Gowth Forecast
6.3.3 IBS-C Drug Gowth Forecast
6.4 Irritable Bowel Syndrome (IBS) Forecast by Application
6.4.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2018-2025)
6.4.2 Global Irritable Bowel Syndrome (IBS) Forecast in Women
6.4.3 Global Irritable Bowel Syndrome (IBS) Forecast in Men
7 Irritable Bowel Syndrome (IBS) Upstream Raw Materials
7.1 Irritable Bowel Syndrome (IBS) Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Irritable Bowel Syndrome (IBS) Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
